Midsummer AB
STO:MIDS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Midsummer AB
STO:MIDS
|
SE |
|
Inventus Mining Corp
XTSX:IVS
|
CA |
|
Zueblin Immobilien Holding AG
SIX:ZUBN
|
CH |
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
Balance Sheet
Balance Sheet Decomposition
Midsummer AB
Midsummer AB
Balance Sheet
Midsummer AB
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6
|
29
|
53
|
111
|
218
|
159
|
2
|
21
|
8
|
29
|
|
| Cash Equivalents |
6
|
29
|
53
|
111
|
218
|
159
|
2
|
21
|
8
|
29
|
|
| Total Receivables |
13
|
6
|
14
|
123
|
149
|
93
|
93
|
116
|
75
|
63
|
|
| Accounts Receivables |
9
|
4
|
13
|
122
|
141
|
89
|
90
|
47
|
30
|
27
|
|
| Other Receivables |
4
|
2
|
2
|
2
|
8
|
3
|
3
|
69
|
45
|
36
|
|
| Inventory |
5
|
11
|
70
|
24
|
27
|
30
|
20
|
31
|
43
|
34
|
|
| Other Current Assets |
1
|
0
|
0
|
1
|
0
|
1
|
132
|
99
|
2
|
5
|
|
| Total Current Assets |
26
|
46
|
138
|
259
|
393
|
283
|
248
|
267
|
128
|
132
|
|
| PP&E Net |
6
|
28
|
37
|
61
|
81
|
155
|
166
|
194
|
223
|
213
|
|
| PP&E Gross |
0
|
0
|
0
|
61
|
81
|
0
|
166
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
36
|
57
|
0
|
54
|
0
|
0
|
0
|
|
| Intangible Assets |
20
|
22
|
31
|
31
|
45
|
53
|
54
|
53
|
53
|
50
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
6
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
5
|
0
|
0
|
0
|
1
|
3
|
0
|
13
|
|
| Total Assets |
51
N/A
|
96
+89%
|
212
+120%
|
352
+66%
|
520
+48%
|
491
-6%
|
469
-4%
|
518
+10%
|
418
-19%
|
413
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7
|
7
|
9
|
16
|
34
|
10
|
21
|
16
|
21
|
15
|
|
| Accrued Liabilities |
1
|
2
|
4
|
10
|
7
|
8
|
11
|
40
|
43
|
32
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
14
|
8
|
6
|
8
|
220
|
17
|
10
|
35
|
|
| Other Current Liabilities |
2
|
15
|
22
|
2
|
7
|
5
|
7
|
28
|
28
|
16
|
|
| Total Current Liabilities |
10
|
24
|
49
|
36
|
55
|
30
|
259
|
100
|
102
|
97
|
|
| Long-Term Debt |
1
|
0
|
20
|
214
|
209
|
208
|
25
|
220
|
237
|
200
|
|
| Deferred Income Tax |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
29
|
36
|
2
|
1
|
0
|
0
|
2
|
3
|
3
|
3
|
|
| Total Liabilities |
39
N/A
|
61
+56%
|
71
+16%
|
251
+253%
|
264
+5%
|
238
-10%
|
286
+20%
|
323
+13%
|
343
+6%
|
301
-12%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
1
|
1
|
2
|
3
|
3
|
5
|
8
|
13
|
|
| Retained Earnings |
46
|
23
|
18
|
58
|
151
|
280
|
349
|
569
|
689
|
775
|
|
| Additional Paid In Capital |
57
|
57
|
157
|
157
|
405
|
530
|
530
|
759
|
756
|
874
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
12
N/A
|
35
+196%
|
141
+303%
|
100
-29%
|
256
+155%
|
253
-1%
|
183
-27%
|
195
+6%
|
75
-61%
|
112
+49%
|
|
| Total Liabilities & Equity |
51
N/A
|
96
+89%
|
212
+120%
|
352
+66%
|
520
+48%
|
491
-6%
|
469
-4%
|
518
+10%
|
418
-19%
|
413
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
35
|
35
|
35
|
93
|
107
|
107
|
207
|
210
|
337
|
|